Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease

Luca Zanoli, Kadir Öztürk, Maria Cappello, +15

Journal of the American Heart Association

Chronic Inflammatory DiseasesImmunologyGastroenterologyIbd PatientsInflammation +18

ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis

Andrea Duminuco, Helen T. Chifotides, Sebastiano Giallongo, +3

Cancers

Iron MetabolismImmunologyBlood CellPathologyNovel Therapeutic Target +21

Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study

Gaetano Giuffrida, Uroš Markovic, Annalisa Condorelli, +7

Haematologica

Mrna Covid-19 VaccinationImmunodeficienciesImmunologyImmunotherapyImmune Dysregulation +14

Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database

Lucia Gozzo, Calogero Vetro, Serena Brancati, +13

Frontiers in Pharmacology

Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine

Giuseppe A. Palumbo, Daniela Cambria, Enrico La Spina, +9

Frontiers in Oncology

ImmunodeficienciesHumoral ResponseImmune RegulationImmunologyImmune System +22

Efficacy and safety of tixagevimab‐cilgavimab versus SARS‐CoV‐2 breakthrough infection in the hematological conditions

Andrea Duminuco, Antonella Nardo, Alessandra Orofino, +13

Cancer

Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers

Sebastiano Giallongo, Andrea Duminuco, Ilaria Dulcamare, +9

Biomolecules

Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting

Andrea Duminuco, Antonella Nardo, Bruno Garibaldi, +5

Journal of Clinical Medicine

Leishmania Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised Patients

Andrea Duminuco, Salvatore Scarso, Alessandra Cupri, +9

Journal of Clinical Medicine

Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab

Andrea Duminuco, Alessandra Romano, Dario Leotta, +9

Frontiers in Oncology